Policy | February 02, 2023
Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Asthma patients are more likely to have an asthma attack during winter
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
The new project further expands the partner's long-term collaboration on new technologies for R&D
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Chyawanprash Special will be available at all Jan Aushadhi Kendras
Subscribe To Our Newsletter & Stay Updated
